Reproductive Health Exam

Correct Answer: A

Rationale: The correct answer is A: Cervical excitation test. The cervical excitation test is positive in pelvic inflammatory disease. This test involves pain or tenderness upon movement of the cervix, indicating inflammation of the pelvic organs. Chadwick sign (choice B) refers to a bluish discoloration of the cervix, vagina, and labia due to increased vascularity and is not a test for PID. Jacquiners sign (choice C) and Palmers sign (choice D) are not recognized clinical signs or tests for PID, making them incorrect choices.

Correct Answer: A

Rationale: The correct answer is Acrosome. The acrosome is an organelle located at the head of a sperm cell and contains enzymes that aid in the penetration of the ovum during fertilization. The Zona pellucida is a glycoprotein membrane surrounding the ovum, not an organelle. Megalis is not a relevant organelle in this context. Therefore, the correct choice is A, Acrosome.

Correct Answer: C

Rationale: A morula is a stage in embryonic development where a solid ball of 12-16 cells is formed after several rounds of mitotic division following fertilization. The zygote is the initial cell formed by the fusion of sperm and egg. Blastomere refers to individual cells in a developing embryo. A blastocyst is a later stage where a fluid-filled cavity forms within the embryo. Therefore, the correct answer is 'Morula.'

Correct Answer: C

Rationale: Congestive heart failure is not typically associated with menopause. Menopause is linked to an increased risk of fractures due to bone density loss, a higher risk of Alzheimer's disease due to hormonal changes, and painful intercourse due to vaginal dryness and thinning of tissues. While cardiovascular health can be affected by menopause, congestive heart failure is not a direct complication associated with menopause.

Correct Answer: C

Rationale: Bromocriptine is primarily used to affect milk production. It is a medication commonly prescribed to help suppress lactation, particularly in cases of postpartum breast engorgement or when stopping breastfeeding. Choices A, B, and D are incorrect as Bromocriptine is not indicated for relieving constriction ring, managing post-partum hemorrhage, or treating pre-eclampsia.